Chronic HDV occurs only with HBV and confers markedly higher risks of rapid progression, cirrhosis, liver failure, and ...
US FDA grants accelerated approval to Gilead’s Hepcludex for the treatment of chronic hepatitis delta virus: Foster City, California Tuesday, May 26, 2026, 10:00 Hrs [IST] Gilea ...
4don MSN
Against all odds: 42-year-old woman defeats HIV, hepatitis B and cancer with rare liver transplant
The patient had been living with Hepatitis B for several years and was diagnosed with HIV around three years ago. Over time, ...
Doctors at Paras Health Gurugram achieved a complex living donor liver transplant on a Liberian patient battling Hepatitis B, ...
A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior vaccination.
Background and Aim: Living donor liver transplantation (LDLT) has particular advantages for Turkey where hepatitis B virus (HBV) infection is the most common cause of cirrhosis, both because LDLT ...
Chronic hepatitis B (CHB) affects more than 254 million people globally, with 1.2 million new infections occurring each year. 1 And while it has the potential to cause severe long-term liver problems ...
Arbutus Biopharma targets chronic hepatitis B with Imdusiran, addressing a vast, unmet medical need. Read more on ABUS stock ...
Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid diagnostic test to identify pregnant women at elevated risk of transmitting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results